SYK Stock Analysis: Buy, Sell, or Hold?
SYK - Stryker Corporation
$335.59
-5.62 (-1.65%)
▼
5d:
-3.18%
30d:
+3.34%
90d:
+15.37%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 6.5/10
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SYK shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SYK shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$507.96
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$315.40
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $335.58, which is considered slightly high relative to its 30-day fair value range of $316.53 to $338.56. The stock's valuation (Forward PE: 20.4) is in line with its historical norms (20.8). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This pessimistic expectation contrasts with the company's recent 44.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is showing sideways momentum. Immediate support is located at $306.90, while resistance sits at $352.49.
Market Sentiment: SYK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $383.73 (+12.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SYK is showing sideways momentum. Immediate support is located at $306.90, while resistance sits at $352.49.
Market Sentiment: SYK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $383.73 (+12.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$316.53 -
$338.56
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($383.73)
Trading Range Analysis
30-Day Trading Range
$316.53 -
$338.56
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$306.90
Resistance Level
$352.49
Current Trend
Sideways
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.35
Wall Street Target
$383.73
(+12.5%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
44.1%
Profit Margin
14.4%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
20.4 vs 20.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$338.47
(-1%)
2-Year Target
$335.76
(-2%)
3-Year Target
$333.08
(-2%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$340.37
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.7%)
$484.28
(+42%)
Base:
(SPY PE: 20.4, Growth: 11.7%)
$475.51
(+39%)
Bear:
(PE: 17.3, Growth: 11.7%)
$404.18
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 37.74 | Current EPS (TTM): $8.63
Bull Case
$695.91
(+104%)
Analyst growth 94.2%, PE expands to 41.5
Base Case
$632.65
(+85%)
Market implied 94.2%, PE stable at 37.7
Bear Case
$221.48
(-35%)
Severe decline -20.0%, PE contracts to 32.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.4 to 20.8
Stabilization Target:
$348.67
(+2.2%)
PE Expansion Potential:
+2.2%
Share & Embed Analysis
Last updated: August 04, 2026 1:16 PM ET
Data refreshes hourly during market hours. Next update: 2:16 PM
Data refreshes hourly during market hours. Next update: 2:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 54 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 62 BUY |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
